Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Robert J Wechsler-Reya
Affiliation
Sanford Burnham Prebys Medical Discovery Institute
ORCID
Career Start Year
1978
Papers
238
H Index
56
Expertise
CM4AI Collaborator
Prashant Mali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
38039965
A road map for the treatment of pediatric diffuse midline glioma.
Cancer Cell
2024
38039965
A road map for the treatment of pediatric diffuse midline glioma.
Cancer Cell
2024
36054558
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int J Cancer
2023
36264168
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.
Cancer Res
2023
36054558
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int J Cancer
2023
37945900
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
Nat Genet
2023
37827699
Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.
J Pharmacol Exp Ther
2023
37802055
Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancer.
Cancer Cell
2023
36516489
Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group.
Neoplasia
2023
37085539
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Nat Commun
2023
36899402
The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas.
Acta Neuropathol Commun
2023
36627300
Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
Nat Commun
2023
37802055
Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancer.
Cancer Cell
2023
37945900
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
Nat Genet
2023
37827699
Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.
J Pharmacol Exp Ther
2023
37085539
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Nat Commun
2023
36516489
Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group.
Neoplasia
2023
36899402
The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas.
Acta Neuropathol Commun
2023
36627300
Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
Nat Commun
2023
36264168
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.
Cancer Res
2023
34077540
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.
Neuro Oncol
2022
36239623
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.
Clin Cancer Res
2022
35835937
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.
Commun Biol
2022
36167467
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
J Immunother Cancer
2022
36219398
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.
Cancer Res
2022
35680424
Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma.
Genes Dev
2022
36131014
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36267874
The long non-coding RNA <i>SPRIGHTLY</i> and its binding partner PTBP1 regulate exon 5 skipping of <i>SMYD3</i> transcripts in group 4 medulloblastomas.
Neurooncol Adv
2022
36446943
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
35977718
Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.
J Proteome Res
2022
36473869
Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
Nat Commun
2022
34077540
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.
Neuro Oncol
2022
35322202
Disruption of GMNC-MCIDAS multiciliogenesis program is critical in choroid plexus carcinoma development.
Cell Death Differ
2022
34985972
Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases.
Sci Transl Med
2022
35309309
Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets.
Front Immunol
2022
34907396
Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.
Nat Neurosci
2022
34890975
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures.
Biomaterials
2022
35121998
The current landscape of immunotherapy for pediatric brain tumors.
Nat Cancer
2022
35680424
Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma.
Genes Dev
2022
35835937
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.
Commun Biol
2022
36446943
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36473869
Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
Nat Commun
2022
36239623
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.
Clin Cancer Res
2022
36131014
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36267874
The long non-coding RNA <i>SPRIGHTLY</i> and its binding partner PTBP1 regulate exon 5 skipping of <i>SMYD3</i> transcripts in group 4 medulloblastomas.
Neurooncol Adv
2022
36167467
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
J Immunother Cancer
2022
35977718
Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.
J Proteome Res
2022
36219398
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.
Cancer Res
2022
34890975
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures.
Biomaterials
2022
35121998
The current landscape of immunotherapy for pediatric brain tumors.
Nat Cancer
2022
1 - 50 of 476
Column Actions
Search
Recommended Authors
Julio A Diaz-Perez
12235University of Miami Miller School of Medicine
Career Start Year
2007
Number of shared co-authors
1
Zhongxin Yu
University of Oklahoma Health Sciences Center
Career Start Year
2005
Number of shared co-authors
0
Jennifer Pogoriler
Children's Hospital Of Philadelphia
Career Start Year
2004
Number of shared co-authors
6
Paritosh C Khanna
Rady Children's Hospital San Diego.
Career Start Year
2003
Number of shared co-authors
6
Robin D LeGallo
University of Virginia Department of Pathology
Career Start Year
2001
Number of shared co-authors
1
Chuong Bui
Nepean Hospital
Career Start Year
1999
Number of shared co-authors
0
Patrizia Moser
Medical University of Innsbruck
Career Start Year
1999
Number of shared co-authors
0
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year
1999
Number of shared co-authors
1
Bret Wehrli
Schulich School of Medicine & Dentistry, Western University
Career Start Year
1998
Number of shared co-authors
1
Sara O Vargas
Boston Children's Hospital
Career Start Year
1997
Number of shared co-authors
6
Jun Matsubayashi
Tokyo Medical University
Career Start Year
1996
Number of shared co-authors
0
Kathleen K Nicol
Nationwide Children's Hospital
Career Start Year
1996
Number of shared co-authors
1
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year
1995
Number of shared co-authors
22
Yeon-Lim Suh
Samsung Medical Center, Sungkyunkwan University College of Medicine
Career Start Year
1994
Number of shared co-authors
0
Weei-Yuarn Huang
Nova Scotia Health Authority
Career Start Year
1992
Number of shared co-authors
0
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year
1992
Number of shared co-authors
2
Louis Letourneau
Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University
Career Start Year
1991
Number of shared co-authors
45
Atsuhiro Kawashima
Kanazawa Medical Center Kanazawa Japan.
Career Start Year
1990
Number of shared co-authors
0
Kavita Garg
Rocky Mountain Regional VA Medical Center, CO University of Colorado
Career Start Year
1989
Number of shared co-authors
0
Sue Hammond
Flinders University Library, Flinders University
Career Start Year
1985
Number of shared co-authors
2
Ossama Tawfik
University of Kansas
Career Start Year
1985
Number of shared co-authors
1
Rex C Bentley
Duke School of Medicine
Career Start Year
1984
Number of shared co-authors
0
Virginia Donovan
New York University Winthrop Hospital
Career Start Year
1982
Number of shared co-authors
0
Maria Sonia S Salamat
University of Wisconsin School of Medicine and Public Health
Career Start Year
1980
Number of shared co-authors
4
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year
1978
Number of shared co-authors
38
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year
1977
Number of shared co-authors
9
David M Parham
Keck School of Medicine, University of Southern California
Career Start Year
1977
Number of shared co-authors
5
Marleta Reynolds
Ann and Robert H Lurie Children's Hospital of Chicago
Career Start Year
1976
Number of shared co-authors
0
Robert C Shamberger
Boston Children's Hospital
Career Start Year
1975
Number of shared co-authors
3
James Sayre
David Geffen School of Medicine at university of california los angeles
Career Start Year
1964
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Michael D Taylor
The Hospital for Sick Children
Co-authored papers
30
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
22
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers
17
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
14
Alexandra Garancher
NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
14
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers
14
Jun Wang
NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
14
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers
13
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
12
Jessica M Rusert
University of California San Diego
Co-authored papers
12
Xiaochong Wu
The Hospital for Sick Children
Co-authored papers
12
Anca Sorana Morrissy
Cumming School of Medicine, University of Calgary
Co-authored papers
12
William A Weiss
University of California san francisco
Co-authored papers
12
James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers
10
David J H Shih
University of Texas MD Anderson Cancer Center Houston
Co-authored papers
10
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers
10
Florence M G Cavalli
Institut Curie, PSL Research University
Co-authored papers
10
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
9
J??ri Reimand
Ontario Institute for Cancer Research
Co-authored papers
9
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers
9
Livia Garzia
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers
9
John R Crawford
Rady Children's Hospital San Diego.
Co-authored papers
9
Marco A Marra
University of British Columbia
Co-authored papers
9
Betty Luu
University of Wollongong
Co-authored papers
9
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers
9
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Co-authored papers
8
Richard A Moore
Co-authored papers
8
Rajeev Vibhakar
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers
8
Steven J M Jones
University of British Columbia
Co-authored papers
8
Hamza Farooq
BioBox Analytics Inc.
Co-authored papers
8
1 - 30